Hyde James C 4
4 · BALCHEM CORP · Filed Feb 14, 2022
Insider Transaction Report
Form 4
BALCHEM CORPBCPC
Hyde James C
Sr. Vice President
Transactions
- Award
Common Stock
2022-02-10+820→ 14,925 total - Award
Common Stock
2022-02-10+2,394→ 17,319 total - Tax Payment
Common Stock
2022-02-10$138.07/sh−738$101,896→ 16,581 total - Award
Stock Option
2022-02-10+2,900→ 42,360 totalExercise: $138.07Exp: 2032-02-10→ Common Stock (2,900 underlying)
Footnotes (4)
- [F1]Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person.
- [F2]Acquired upon the settlement of performance shares granted on February 13, 2019, based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period as a result of the satisfaction of those performance criteria.
- [F3]738 of the 2394 shares that vested February 10, 2022 were withheld to cover withholding taxes due upon vesting.
- [F4]Options vest 20% Year 1; 40% Year 2; and 40% Year 3.